Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
Investors
  • Overview
  • Corporate News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Leadership
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
    • IRS Form 8937 for 2019 Reverse Stock Split
    • IRS Form 8937 for 2023 Reverse Stock Split
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Governance Documents
  • Analyst Coverage

Press Releases

  • Corporate News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Feb 5, 2016

Aethlon Medical to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference on February 10, 2016

Feb 4, 2016

Aethlon Medical Announces Fiscal 2016 Third Quarter Results

Feb 3, 2016

Aethlon Medical Announces Dengue Virus Study Approval, Chikungunya Virus Capture Data and Completion of U.S. Principal Investigator Training

Feb 1, 2016

Aethlon Medical to Present at the 18th Annual BIO CEO & Investor Conference

Jan 29, 2016

Aethlon Medical To Host Third Quarter Fiscal 2016 Investor Call on February 4, 2016

Jan 12, 2016

Aethlon Medical's Exosome Sciences To Participate In Clinical Research Study To Diagnose Chronic Traumatic Encephalopathy (CTE)

Nov 16, 2015

Aethlon Medical Announces Fiscal 2016 Second Quarter Results

Nov 10, 2015

Aethlon Medical to Participate in the IN3 Medical Device 360 Summit

Oct 26, 2015

Aethlon Medical To Host Second Quarter Fiscal 2016 Investor Call on November 16, 2015

Sep 28, 2015

Aethlon Medical Extends Contract with the Defense Advanced Research Projects Agency

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.